China-backed NeuCyber claims it's 3 years behind Neuralink, but targets 50 patient implants by year-end. China designates BCIs as core strategic priority.

While the United States and Europe are moving cautiously forward with clinical trials, China is racing toward the commercialization of brain implants.

Leading Chinese state-backed brain-computer interface (BCI) startup NeuCyber Neurotech said its ​most cutting-edge product is still three years behind Elon Musk's Neuralink, as Beijing races to expand ...

Advancements in Clinical Applications It’s pretty amazing to see how far brain-computer interfaces have come, especially when ...

The recently launched ai6 Labs is focused on advancing the Company’s revolutionary neural AI technology powered by non-invasive electromyography (EMG) technology and the Mudra platform, supporting a ...

Brain-computer interface, an innovative technology frontier that establishes a direct link between the human brain and ...

China has approved its first implantable brain-computer interface (BCI) device for commercial use, marking a major step forward in the ...

China’s medical regulator has granted a world-first commercial green light to a brain-computer interface, with a system ...

A Chinese startup developing non-invasive brain–computer interface technology has raised $21.6 million in early funding as global investment in neural ...